Use of antibiotics in sepsis and septic shock

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:10 / 10
页数:1
相关论文
共 50 条
  • [21] Analysis of Race and Time to Antibiotics Among Patients with Severe Sepsis or Septic Shock
    Tracy E. Madsen
    Anthony M. Napoli
    Journal of Racial and Ethnic Health Disparities, 2017, 4 : 680 - 686
  • [22] Antibiotics in sepsis and septic shock: Like everything else in life, timing is everything
    Zubert, Shelly
    Funk, Duane J.
    Kumar, Anand
    CRITICAL CARE MEDICINE, 2010, 38 (04) : 1211 - 1212
  • [23] To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock
    Neugebauer, Edmund A. M.
    CRITICAL CARE MEDICINE, 2007, 35 (12) : 2855 - 2856
  • [24] Ketamine use for endotracheal intubation in severe sepsis and septic shock
    Jo, Seok Woo
    Hwang, Sung Yeon
    Jo, Ik Joon
    Lee, Tae Rim
    Yoon, Hee
    Cha, Won Chul
    Sim, Min Seob
    Shin, Tae Gun
    SIGNA VITAE, 2018, 14 (02) : 24 - 30
  • [25] Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock
    Kreyrnann, K. Georg
    de Heer, Geraldine
    Nierhaus, Axel
    Kluge, Stefan
    CRITICAL CARE MEDICINE, 2007, 35 (12) : 2677 - 2685
  • [26] What Definition Should We Use for Sepsis and Septic Shock?
    Sprung, Charles L.
    Trahtemberg, Uriel
    CRITICAL CARE MEDICINE, 2017, 45 (09) : 1564 - 1567
  • [27] A RATIONALE FOR THE PROPHYLACTIC USE OF MONOPHOSPHORYL LIPID A IN SEPSIS AND SEPTIC SHOCK
    GUSTAFSON, GL
    RHODES, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (01) : 269 - 275
  • [28] Sepsis and Septic Shock Preface
    Kalil, Andre C.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 42 (05) : 639 - 640
  • [29] Severe Sepsis and Septic Shock
    Angus, Derek C.
    van der Poll, Tom
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09): : 840 - 851
  • [30] Pharmacogenomics in sepsis and septic shock
    Shaw, D
    Russell, JA
    Walley, KR
    DRUG DEVELOPMENT RESEARCH, 2005, 64 (04) : 181 - 194